Flurbiprofen film spraying agent containing plant-derived chitosan and preparation method of flurbiprofen film spraying agent
The fluorobiprofen spray formulation with plant-derived chitosan and a dual alcohol-ester system addresses the need for efficient and sustained drug delivery, minimizing systemic side effects and improving patient compliance.
Patent Information
- Application Number
- CN202510576655.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2025-05-06
- Publication Date
- 2025-07-11
AI Technical Summary
Current topical formulations for fluorobiprofen lack a convenient and efficient delivery system that provides rapid and sustained drug release, while minimizing systemic side effects and improving patient compliance.
A fluorobiprofen spray formulation using plant-derived chitosan as a film-forming agent, combined with a 'dual alcohol-ester' permeation system, enhances skin penetration by disrupting the stratum corneum and promoting rapid and sustained drug release, while maintaining bio-compatibility and reducing skin retention.
The formulation achieves rapid and sustained drug release, reduces gastrointestinal side effects, and improves patient compliance by providing a convenient, precise, and targeted delivery system.
Smart Images

Figure BDA0005388776770000051 
Figure BDA0005388776770000061 
Figure BDA0005388776770000071
Abstract
Description
Technical Field
[0001] This application relates to the technical field of medicine, and particularly relates to a flurbiprofen spray film containing plant-derived chitosan and a preparation method thereof. Background Art
[0002] Flurbiprofen belongs to non-steroidal anti-inflammatory drugs, and its effects include anti-inflammatory, analgesic, and antipyretic. Its pharmacokinetic characteristics are a relatively long half-life, which can reduce the frequency of medication and improve patient compliance. The advantages of the topical dosage form of flurbiprofen in local treatment are: good transdermal absorption, suitable for local treatment of arthritis, and reduction of gastrointestinal side effects.
[0003] Spray films have obvious advantages in terms of convenience of use and coverage effect: single-handed operation, no need to contact the affected area. The spray film forms a uniform film through spraying, avoiding direct hand application and reducing the risk of contamination. Quick film formation and good adhesion: It quickly forms a breathable protective film after spraying, tightly adheres to skin folds or joint movement parts (such as fingers, knees), and is not easily rubbed off due to friction or movement; while creams may be rubbed off due to sweating or clothing friction. Precise and controllable dosage: The spray film controls the single spray volume through a quantitative valve, avoiding uneven dosage caused by different extrusion pressures of creams. Faster drug transdermal absorption and onset speed: The solvent of the spray film can temporarily increase the permeability of the stratum corneum, promote rapid drug penetration, and shorten the onset time compared with creams. High local drug concentration: After film formation, it forms a closed environment, reducing drug volatilization or loss, maintaining a high local concentration, and enhancing the anti-inflammatory and analgesic effects. Avoiding the waste of the "first-pass effect": Similar to creams, the spray film acts directly on the target site, reducing systemic absorption, but the uniform distribution of the spray film may reduce the waste of drugs on the skin surface. Applicability to multiple parts: Especially suitable for areas with dense hair (such as the scalp), flexor sides of joints or uneven skin surfaces, and the spray film can cover areas where creams are difficult to apply evenly. No greasy feeling and high comfort: The spray film has no residue after drying, does not affect daily activities or dressing; creams may leave an oily film, resulting in a sticky feeling or clothing contamination. Portable and hygienic: The small spray bottle is convenient to carry around, and there is no need to wash hands during use, which is suitable for outdoor or emergency situations (such as sports injuries). Precise targeting and lower systemic exposure: The quantitative spraying and local retention characteristics of the spray film further reduce the amount of drug entering the blood through the skin and reduce the incidence of systemic side effects (such as gastrointestinal discomfort). For children or patients with poor compliance: The spray film is easy to operate and has no tactile burden, and is more easily accepted by children or patients who are resistant to application.
[0004] Currently, only the patch dosage form is used more in local topical preparations. Therefore, developing a new spray film dosage form of flurbiprofen is of great significance. Summary of the Invention
[0005] In order to solve the above technical problems, this application provides a flurbiprofen spray film containing plant-derived chitosan and a preparation method thereof.
[0006] The present application provides a flurbiprofen spray film containing plant-derived chitosan, specifically including the following components in parts by weight: 1-5 parts of active pharmaceutical ingredient, 2-6 parts of chitosan, 0.5-1 part of octyl acetylleucinate, 15-40 parts of organic alcohol, and 50-80 parts of water; the active pharmaceutical ingredient is selected from one or more of flurbiprofen and sodium flurbiprofen; the chitosan is selected from one or more of plant-derived chitosan and plant-derived carboxymethylated chitosan; the organic alcohol is composed of isopropanol and propylene glycol in a weight ratio of 1-3:0.5-1; the pH of the flurbiprofen spray film is 5.0-7.0.
[0007] The technical solution provided by the present application uses chitosan as a film-forming agent in combination with flurbiprofen, adopting a "dual alcohol-ester" synergistic penetration system: isopropanol rapidly opens the stratum corneum channels, and octyl acetylleucinate inserts its long octyl chain (C8) into the lipid bilayer of the stratum corneum, disrupting the ordered arrangement of ceramides, cholesterol, etc., and temporarily expanding the intercellular channels through hydrophobic interactions to promote the diffusion of the lipophilic drug flurbiprofen. As an amphiphilic molecule (containing a hydrophilic acetylleucine group + a hydrophobic octyl chain), it can increase the solubility of the drug in both the stratum corneum and the preparation. By competitively binding to stratum corneum proteins, it reduces the retention of the drug on the skin surface and enhances the permeability of flurbiprofen. Propylene glycol serves as a drug carrier and a secondary penetration enhancer, which can significantly enhance the permeability of the film and maintain rapid and steady release.
[0008] In addition, the chitosan derived from plant raw materials in the present application has the advantages of low impurities and good biocompatibility, and the provided flurbiprofen spray film has good biocompatibility; moreover, the flurbiprofen spray film is prepared at a low temperature (<50°C) throughout the process, which is suitable for industrial scale-up.
[0009] Preferably, the flurbiprofen spray film specifically includes the following components in parts by weight: 2-4 parts of flurbiprofen or sodium flurbiprofen, 3-5 parts of plant-derived chitosan, 0.6-0.9 part of octyl acetylleucinate, 20-35 parts of organic alcohol, and 60-70 parts of water.
[0010] Preferably, the pH of the flurbiprofen spray film is 5.5-6.5.
[0011] Preferably, the chitosan is obtained by compounding plant-derived chitosan with a low molecular weight of 50-100 kDa and plant-derived chitosan with a medium molecular weight of 150-300 kDa in a weight ratio of 1-2:1-2.
[0012] Preferably, the chitosan is obtained by compounding plant-derived carboxymethylated chitosan with a low molecular weight of 50-100 kDa and plant-derived carboxymethylated chitosan with a medium molecular weight of 150-300 kDa in a weight ratio of 1-2:1-2.
[0013] In this application, chitosan and flurbiprofen are combined, and the spray film agent product adopts a dynamic film-forming technology: low-molecular-weight chitosan (50-100 kDa) and medium-molecular-weight chitosan (150-300 kDa) are compounded to further improve the performance of the flurbiprofen spray film agent.
[0014] Preferably, the plant-derived chitosan is prepared from the chitin of edible fungi; the edible fungi are selected from one or more of Pleurotus ostreatus, Volvariella volvacea, Lentinula edodes, and Agaricus bisporus.
[0015] The chitosan used in this application serves as a film-forming material in the spray film agent and is derived from plants, more specifically from edible fungi. Chitosan derived from edible fungi has several advantages compared to traditional crustacean sources (such as shrimp and crab shells). It has strong renewability: mushrooms (especially mycelia or specific fungal species) have a short growth cycle and can be cultivated using agricultural waste (such as straw and wood chips), with high resource utilization efficiency. It reduces marine dependence: traditional chitosan relies on shrimp and crab shells, which may exacerbate the pressure on marine resources, while mushroom cultivation is not restricted by fishery resources. It has no allergy risk: it avoids the allergens that may be carried by crustacean sources (suitable for people with seafood allergies). It does not require demineralization treatment: crustacean chitin needs to be treated with strong acid to remove calcium (calcium carbonate), while fungal chitin does not contain a large amount of minerals, simplifying the extraction steps, reducing costs and pollution. It has higher purity: the chitin in the mushroom cell wall structure binds less to proteins and pigments, making purification easier, with fewer impurities in the product and a more uniform molecular weight distribution. It is energy-saving and environmentally friendly: it reduces the use of chemical reagents (such as hydrochloric acid and sodium hydroxide) and eases the difficulty of wastewater treatment. It has low immunogenicity: the structure of fungal chitosan may be closer to natural polysaccharides in the human body, making it suitable for medical applications (drug carriers). It has antibacterial activity: chitosan derived from mushrooms has a more significant inhibitory effect on certain pathogenic bacteria (such as Escherichia coli and Staphylococcus aureus). It has customizable molecular weight: by controlling the fungal culture conditions or enzymatic hydrolysis process, it is easier to adjust the molecular weight and deacetylation degree of chitosan to meet different requirements.
[0016] Preferably, the preparation method of the plant-derived chitosan specifically includes the following steps: Chitin extraction: Under the condition that the solid-liquid weight ratio is 1:10-15, place the edible fungus powder in a 1-2 mol / L NaOH aqueous solution, stir in a water bath at 70-90 °C for 2-4 h, centrifuge to remove the supernatant, wash with water until neutral to remove proteins and some pigments; then use a 3-5 wt% H2O2 aqueous solution, adjust the pH to 9-10 with sodium hydroxide solution, soak at 60-70 °C for 1-2 h, centrifuge and wash with water until neutral to remove residual pigments to obtain chitin; Deacetylation to prepare chitosan oligosaccharide: Under the condition that the solid-liquid weight ratio is 1:5 - 15, using 40 - 50% NaOH solution, reacting at 100 - 120 °C for 4 - 6 h to obtain an alkaline polysaccharide solution; Purification: Alcohol precipitation, drying to obtain crude chitosan oligosaccharide; Preparation of chitosan oligosaccharide: Under the condition that the solid-liquid weight ratio is 1:10 - 15, using 0.1 - 0.5 mmol / L dilute hydrochloric acid or nitric acid aqueous solution, hydrolyzing at 60 - 80 °C for 2 - 4 h, after neutralization, obtaining products with different molecular weights by gel chromatography column or ultrafiltration, and then through drying, plant-derived chitosan oligosaccharide is obtained.
[0017] Preferably, the preparation method of the plant-derived carboxymethylated chitosan oligosaccharide specifically includes the following steps: Swelling: Under the condition that the solid-liquid weight ratio is 1:5 - 15, dispersing the plant-derived chitosan oligosaccharide powder in 40 - 50% NaOH solution, swelling at room temperature for 1 - 2 h; Etherification: Transferring the swollen chitosan oligosaccharide suspension to a mixed solution of isopropanol / water with a volume ratio of 1.5 - 2.5:1, adding chloroacetic acid in portions at 50 - 60 °C, adjusting the pH to 8 - 9 with NaOH, and stirring and reacting for 4 - 6 h; the molar ratio of chitosan oligosaccharide to chloroacetic acid is 1:1.5 - 2; Neutralization and purification: Adjusting the reaction solution to neutral with dilute hydrochloric acid to terminate the reaction; Precipitation washing: Adding anhydrous ethanol to precipitate the product, centrifuging to collect the precipitate; washing with 70 - 80% ethanol 3 - 4 times to remove unreacted chloroacetic acid and salts; loading into a gel chromatography column or ultrafiltration to obtain products with different molecular weights, and then through drying, plant-derived carboxymethylated chitosan oligosaccharide is obtained.
[0018] Preferably, the organic alcohol consists of isopropanol and propylene glycol with a weight ratio of 1.5 - 2.5:0.6 - 0.9.
[0019] Preferably, the organic alcohol consists of isopropanol and propylene glycol with a weight ratio of 2:0.7.
[0020] Through experimental analysis, it can be known that in this application, the mixture of isopropanol and propylene glycol with the above weight ratio is used as the organic alcohol, further improving the performance of the flurbiprofen spray film.
[0021] On the other hand, this application provides a preparation method of the above flurbiprofen spray film, specifically including the following steps in sequence: Adding chitosan oligosaccharide to dissolve in water, and then adding the active pharmaceutical ingredient to obtain Phase A; Dissolving acetyl leucine octyl ester in the organic alcohol to obtain Phase B; Mixing Phase A and Phase B, adjusting the pH to obtain the flurbiprofen spray film.
[0022] In summary, the technical solution of the present application has the following effects: The present application innovatively discovers that the flurbiprofen spray film contains chitosan and octyl acetylleucinate, which can not only exert effects rapidly but also have long-acting skin permeability. Compared with oral flurbiprofen, the skin topical spray film can effectively avoid gastrointestinal adverse reactions, is easy to use, and compared with external cream and ointment, due to forming a film by spraying, it can form a film without additional smearing, and can be used for anti-inflammatory, antipyretic and analgesic purposes.
[0023] The prescription ingredients and process of the flurbiprofen spray film provided by the present application are simple, suitable for large-scale industrial production, and meet the pharmaceutical requirements.
[0024] The flurbiprofen spray film containing plant-derived chitosan provided by the present application increases the types and applicability of flurbiprofen topical preparations.
[0025] The flurbiprofen spray film of the present application is applicable to the analgesia and anti-inflammation of diseases and symptoms such as osteoarthritis, degenerative arthritis, scapulohumeral periarthritis, tendon / tendinitis, peritendinitis, lateral epicondylitis of the humerus (tennis elbow), muscle pain, swelling and pain caused by trauma, etc. Detailed implementation manners
[0026] The following further describes the present application in detail in combination with examples, comparative examples and performance detection tests, and these examples should not be construed as limiting the scope claimed by the present application.
[0027] Preparation examples Preparation example 1 Preparation example 1 provides a plant-derived chitosan and a plant-derived carboxymethylated chitosan.
[0028] The preparation methods of the plant-derived chitosan and the plant-derived carboxymethylated chitosan in this preparation example are specifically as follows.
[0029] Chitin extraction: Under the condition of a solid-liquid weight ratio of 1:12, 0.1 kg of edible mushroom powder is placed in 1 kg of 1.5 mol / L NaOH aqueous solution, stirred in a water bath at 80 °C for 3 h, the supernatant is removed by centrifugation, washed with water until neutral, and proteins and part of pigments are removed; then, with a 4 wt% H2O2 aqueous solution, the pH is adjusted to 9.5 with sodium hydroxide solution, soaked and treated at 65 °C for 1.5 h, centrifuged and washed with water until neutral, and residual pigments are removed to obtain chitin; Deacetylation to prepare chitosan: Under the condition of a solid-liquid weight ratio of 1:10, the above chitin is added to a 45% NaOH solution and reacted at 110 °C for 5 h to obtain an alkaline polysaccharide solution; Purification: Alcohol precipitation and drying to obtain crude chitosan; Preparation of chitosan oligosaccharide: Under the condition of a solid-liquid weight ratio of 1:12, use 0.25 mmol / L dilute hydrochloric acid aqueous solution, hydrolyze at 70 °C for 3 h. After neutralization, ultrafiltration is used to obtain products with different molecular weights, and then pre-freeze at -40 °C and vacuum dry to keep the product structure intact; thus, plant-derived chitosan oligosaccharide is obtained.
[0030] Swelling: Under the condition of a solid-liquid weight ratio of 1:10, disperse the plant-derived chitosan oligosaccharide powder in 45% NaOH solution and swell at room temperature for 1.5 h; Etherification: Transfer the swollen chitosan oligosaccharide suspension to 5 weight times of the reaction medium (the reaction medium is a mixture of isopropanol / water with a volume ratio of 2:1), add chloroacetic acid in portions at 55 °C, adjust the pH to 8.5 with NaOH, and stir and react for 5 h; the molar ratio of chitosan oligosaccharide to chloroacetic acid is 1:1.8; Neutralization and purification: Adjust the reaction solution to neutral with dilute hydrochloric acid to terminate the reaction; Precipitation and washing: Add anhydrous ethanol to precipitate the product, collect the precipitate by centrifugation; wash it 3 times with 75% ethanol to remove unreacted chloroacetic acid and salts; ultrafilter to obtain products with different molecular weights; then pre-freeze at -40 °C and vacuum dry to obtain plant-derived carboxymethylated chitosan oligosaccharide. Examples
[0031] Examples 1 - 5 Examples 1 - 5 respectively provide a flurbiprofen spray film.
[0032] The differences among the above examples are as follows: The dosages of each component in the flurbiprofen spray film are different, as specifically shown in Table 1.
[0033] The preparation method of the flurbiprofen spray film in the above examples is specifically as follows.
[0034] Add the plant-derived carboxymethylated chitosan oligosaccharide (prepared from Preparation Example 1, which is a 1:1 compound of plant-derived carboxymethylated chitosan oligosaccharide with a low molecular weight of 50 - 100 kDa and plant-derived carboxymethylated chitosan oligosaccharide with a medium molecular weight of 150 - 300 kDa) into water and dissolve it, then add flurbiprofen, and then add sodium hydroxide to adjust the pH to 6.0 to obtain Phase A; Dissolve octyl acetylleucinate in organic alcohol (composed of isopropanol and propylene glycol with a weight ratio of 2:0.7) to obtain Phase B; Mix Phase A and Phase B, and fill the obtained solution into a spray bottle to obtain the flurbiprofen spray film.
[0035] Table 1 Dosages of each component in the flurbiprofen spray film in Examples 1 - 5 Examples 6 - 10 Examples 6-10 each provide a flurbiprofen spray film agent.
[0036] The differences between the above examples and Example 1 are specifically as follows: the plant-derived chitosan is different, as shown below.
[0037] In Example 6: An equal amount of plant-derived chitosan (prepared in Preparation Example 1, obtained by mixing plant-derived chitosan with a low molecular weight of 50-100 kDa and plant-derived chitosan with a medium molecular weight of 150-300 kDa in a ratio of 1:1) is used to replace the plant-derived carboxymethylated chitosan.
[0038] In Example 7: Plant-derived carboxymethylated chitosan with a low molecular weight of 50-100 kDa (prepared in Preparation Example 1) is used as the plant-derived chitosan.
[0039] In Example 8: The plant-derived carboxymethylated chitosan is prepared in Preparation Example 1 and is obtained by mixing plant-derived carboxymethylated chitosan with a low molecular weight of 50-100 kDa and plant-derived carboxymethylated chitosan with a medium molecular weight of 150-300 kDa in a ratio of 1:5.
[0040] In Example 9: The plant-derived carboxymethylated chitosan is prepared in Preparation Example 1 and is obtained by mixing plant-derived carboxymethylated chitosan with a low molecular weight of 50-100 kDa and plant-derived carboxymethylated chitosan with a medium molecular weight of 150-300 kDa in a ratio of 2:1.
[0041] In Example 10: The plant-derived carboxymethylated chitosan is prepared in Preparation Example 1 and is obtained by mixing plant-derived carboxymethylated chitosan with a low molecular weight of 50-100 kDa and plant-derived carboxymethylated chitosan with a medium molecular weight of 150-300 kDa in a ratio of 1:2.
[0042] Other process parameters in the above examples are the same as those in Example 1.
[0043] Examples 11-14 Examples 11-14 each provide a flurbiprofen spray film agent.
[0044] The differences between the above examples and Example 1 are specifically as follows: the types of organic alcohols are different, as shown below.
[0045] In Example 11: The organic alcohol consists of isopropyl alcohol and propylene glycol in a weight ratio of 1:1.
[0046] In Example 12: The organic alcohol consists of isopropyl alcohol and propylene glycol in a weight ratio of 3:0.5.
[0047] In Example 13: The organic alcohol consists of isopropyl alcohol and propylene glycol in a weight ratio of 1.5:0.9.
[0048] In Example 14: The organic alcohol consists of isopropyl alcohol and propylene glycol with a weight ratio of 2.5:0.6.
[0049] In the above examples, other process parameters are the same as those in Example 1.
[0050] Comparative Example Comparative Examples 1 - 3 Comparative Examples 1 - 3 respectively provide a flurbiprofen spray film agent.
[0051] The difference in the above - mentioned comparative examples is that the dosages of each component in the flurbiprofen spray film agent are different, as shown in Table 2 specifically.
[0052] The preparation method of the flurbiprofen spray film agent in the above - mentioned comparative examples is specifically as follows.
[0053] 1) Dissolve flurbiprofen in ethanol and stir to obtain a solution. 2) Measure an appropriate amount of purified water, add methylparaben and propylparaben, and stir to dissolve at 80 °C to obtain a transparent and homogeneous solution. Cool to room temperature and set aside. 3) Add the solution in 1) to 2), and stir evenly to obtain a mixed solution. 4) Add glycerol and peppermint oil to the mixed solution, stir evenly, and then add purified water to the required amount to obtain the product. 5) Fill the obtained solution into a spray bottle and equip it with a quantitative spray pump.
[0054] Table 2 Dosages of each component in the flurbiprofen spray film agent in Comparative Examples 1 - 3 Comparative Examples 4 - 7 Comparative Examples 4 - 7 respectively provide a flurbiprofen spray film agent.
[0055] The differences between the above - mentioned comparative examples and Example 3 are specifically as follows.
[0056] In Comparative Example 4: An equal amount of chitosan (purchased from Merck, product number M81809, Mw: 800 - 1000) is used to replace the plant - derived chitosan.
[0057] In Comparative Example 5: The organic alcohol consists of ethanol and glycerol with a weight ratio of 2:0.7.
[0058] In Comparative Example 6: The organic alcohol consists of isopropyl alcohol and propylene glycol with a weight ratio of 1:3.
[0059] In Comparative Example 7: An equal amount of propylparaben is used to replace octyl acetylleucinate.
[0060] In the above - mentioned comparative examples, other process parameters are the same as those in Example 1.
[0061] Performance detection test viscosity: Using a Brookfield (Brookfield Model D220) viscometer, rotor 95#, rotation speed 100 rpm; specific method: Take the sample, use a rotational viscometer to measure the viscosity, the measurement temperature is 32°C, record the results; the results are shown in Table 2.
[0062] Diffusibility: Measured by the RT800 Ruituo automatic sampling transdermal diffusion system, measurement method: Franz diffusion cell method, device: The Franz diffusion cell includes a supply cell and a receiving cell, separated by a semi-permeable membrane in the middle. Sample preparation: Spray the flurbiprofen film-forming agent evenly on the semi-permeable membrane and fix it in the diffusion cell. Release medium: Select phosphate buffer solution with pH = 7.2 as the receiving solution, place the diffusion cell in an environment with a constant temperature of 32°C ± 1°C. Stirrer speed: 300 rpm, sample at the set time points: 2, 3, 4, 6, and 8 h, analyze the drug content in the receiving solution by HPLC, and calculate the cumulative release amount of the drug. The measurement temperature is 32°C, record the results.
[0063] Test results: As shown in Table 3.
[0064] Table 3 Performance test results of flurbiprofen film-forming agent in examples and comparative examples From the test results in the above table, it can be seen that in Comparative Examples 1-3, the technical solutions adopted the formulation excipients of ethanol + glycerol + peppermint oil + methylparaben + propylparaben. In Comparative Example 4, chitosan was used to replace plant-derived chitosan oligosaccharide in equal amounts. In Comparative Example 5, the organic alcohol consisted of ethanol and glycerol with a weight ratio of 2:0.7. In Comparative Example 6, the organic alcohol consisted of isopropanol and propylene glycol with a weight ratio of 1:3. In Comparative Example 7, propylparaben was used to replace octyl acetylleucinate in equal amounts; the prepared flurbiprofen film-forming agent had poor viscosity and poor drug release effect.
[0065] In contrast, the technical solution provided by this application combines chitosan oligosaccharide with flurbiprofen and adopts a "dual alcohol-ester" synergistic penetration system. The prepared flurbiprofen film-forming agent achieves a balance between adhesion and sustained release performance, forms a film quickly, and has a long-lasting release effect.
[0066] By comparing the test results of Examples 1, 6-10, it can be seen that this application uses plant-derived carboxymethylated chitosan with a low molecular weight of 50-100 kDa and plant-derived carboxymethylated chitosan with a medium molecular weight of 150-300 kDa in a compounding ratio of 1-2:1-2 as plant-derived chitosan oligosaccharide, further improving the performance of the flurbiprofen film-forming agent.
[0067] By comparing the detection results of Examples 1, 11 - 14, it can be seen that in this application, an organic alcohol composed of isopropanol and propylene glycol with a weight ratio of 1.5 - 2.5:0.6 - 0.9 is used, further improving the performance of the flurbiprofen spray film agent.
[0068] Although the present invention has been described in detail with general descriptions and specific embodiments above, based on the present invention, some modifications or improvements can be made, which are obvious to those skilled in the art. Therefore, these modifications or improvements made without departing from the spirit of the present invention all fall within the scope of protection required by the present invention.
Claims
1. A flurbiprofen spray film containing plant-derived chitosan, characterized in that, Specifically, it includes the following components in parts by weight: 1 - 5 parts of active pharmaceutical ingredient, 2 - 6 parts of chitosan, 0.5 - 1 part of octyl acetylleucinate, 15 - 40 parts of organic alcohol, and 50 - 80 parts of water; The active pharmaceutical ingredient is selected from one or more of flurbiprofen and flurbiprofen sodium; The chitosan is selected from one or more of plant - derived chitosan and plant - derived carboxymethylated chitosan; The organic alcohol is composed of isopropanol and propylene glycol in a weight ratio of 1 - 3:0.5 - 1; The pH of the flurbiprofen spray film agent is 5.0 - 7.
0.
2. The flurbiprofen spray film agent according to claim 1, characterized in that, Specifically, it includes the following components in parts by weight: 2 - 4 parts of flurbiprofen or flurbiprofen sodium, 3 - 5 parts of plant - derived chitosan, 0.6 - 0.9 part of octyl acetylleucinate, 20 - 35 parts of organic alcohol, and 60 - 70 parts of water.
3. The flurbiprofen spray film according to claim 1, characterized in that, The chitosan is obtained by compounding plant - derived chitosan with a low molecular weight of 50 - 100 kDa and plant - derived chitosan with a medium molecular weight of 150 - 300 kDa in a weight ratio of 1 - 2:1 - 2.
4. The flurbiprofen spray film according to claim 1, characterized in that, The chitosan is obtained by compounding plant - derived carboxymethylated chitosan with a low molecular weight of 50 - 100 kDa and plant - derived carboxymethylated chitosan with a medium molecular weight of 150 - 300 kDa in a weight ratio of 1 - 2:1 - 2.
5. The flurbiprofen spray film agent according to claim 1, characterized in that The plant - derived chitosan is prepared from chitin of edible fungi; the edible fungi are selected from one or more of Pleurotus ostreatus, Volvariella volvacea, Lentinula edodes, and Agaricus bisporus.
6. The flurbiprofen spray film according to claim 1, wherein The preparation method of the plant - derived chitosan specifically includes the following steps: Chitin extraction: Under the condition of a solid - liquid weight ratio of 1:10 - 15, put the edible fungus powder into a 1 - 2 mol / L NaOH aqueous solution, stir in a water bath at 70 - 90 °C for 2 - 4 h, centrifuge to remove the supernatant, wash with water until neutral to remove proteins and some pigments; then use a 3 - 5 wt% H2O2 aqueous solution, adjust the pH to 9 - 10 with sodium hydroxide solution, soak at 60 - 70 °C for 1 - 2 h, centrifuge and wash with water until neutral to remove residual pigments to obtain chitin; Deacetylation to prepare chitosan: Under the condition of a solid - liquid weight ratio of 1:5 - 15, use a 40 - 50% NaOH solution, react at 100 - 120 °C for 4 - 6 h to obtain an alkaline polysaccharide solution; Purification: Alcohol precipitation, drying to obtain the crude chitosan; Preparation of chitosan: Under the condition of a solid - liquid weight ratio of 1:10 - 15, use a 0.1 - 0.5 mmol / L dilute hydrochloric acid or nitric acid aqueous solution, hydrolyze at 60 - 80 °C for 2 - 4 h, after neutralization, obtain products with different molecular weights by gel chromatography column or ultrafiltration, and then through drying, the plant - derived chitosan is obtained.
7. The flurbiprofen spray film according to claim 1, wherein The preparation method of the plant - derived carboxymethylated chitosan specifically includes the following steps: Swelling: Under the condition of a solid - liquid weight ratio of 1:5 - 15, disperse the plant - derived chitosan powder in a 40 - 50% NaOH solution, and swell at room temperature for 1 - 2 h; Etherification: Transfer the swollen chitosan suspension to a mixed solution of isopropanol / water with a volume ratio of 1.5 - 2.5:1, add chloroacetic acid in portions at 50 - 60 °C, adjust the pH to 8 - 9 with NaOH, and stir and react for 4 - 6 h; the molar ratio of chitosan to chloroacetic acid is 1:1.5 - 2; Neutralization and purification: Adjust the reaction solution to neutral with dilute hydrochloric acid to terminate the reaction; Precipitate washing: Add anhydrous ethanol to precipitate the product, and centrifuge to collect the precipitate; Wash it 3-4 times with 70-80% ethanol to remove unreacted chloroacetic acid and salts; Load it into a gel chromatography column or ultrafiltrate to obtain products with different molecular weights, and then dry it to obtain plant-derived carboxymethylated chitosan.
8. The flurbiprofen spray film according to claim 1, characterized in that, The organic alcohol consists of isopropanol and propylene glycol with a weight ratio of 1.5-2.5:0.6-0.
9.
9. The flurbiprofen spray film agent according to claim 8, characterized in that, The organic alcohol consists of isopropanol and propylene glycol with a weight ratio of 2:0.
7.
10. The preparation method of the flurbiprofen spray film according to any one of claims 1-9, characterized in that, Specifically, it includes the following steps in sequence: After dissolving chitosan in water, add the raw drug to obtain phase A; Dissolve octyl acetylleucinate in the organic alcohol to obtain phase B; Mix phase A and phase B, adjust the pH to obtain the flurbiprofen spray film.
Citation Information
Patent Citations
Flurbiprofen coating agent and preparation method thereof
CN105232496A
Transdermal delivery system of terbinafine hydrochloride long-acting spraying agent
CN107638423A
Topical film-forming spray
CN108738309A
Hair growth-promoting film spraying agent and preparation method thereof
CN110193017A
Preparation method of skin repair spray and product thereof
CN116531327A
